https://myriad.com/gene-results/BRCA1/1/
Men with BRCA1 mutations have an elevated risk for breast and prostate cancer. The increased risk for prostate cancer may be most significant at younger ages.
https://myriad.com/genetic-tests/bracanalysiscdx-germline-test/
Pancreatic cancer. Prostate cancer. Deleterious or suspected deleterious mutations in BRCA1 and BRCA2 genes. LYNPARZA ® (olaparib) ...
https://investor.myriad.com/news-releases/news-release-detail/12331/
Apr 17, 2017 ... Dramatically declining VUS rates. Myriad has reduced the BRCA1/2 VUS rates from 40 percent to 1.6 percent, dramatically lower than any other ...
https://investor.myriad.com/news-releases/news-release-detail/11526/
According to estimates, women with an altered BRCA1 or BRCA2 gene have a 56 to 87 percent risk to develop breast cancer by age 70, whereas the risk for women in ...
https://investor.myriad.com/news-releases/news-release-detail/10686/
Myriad discovered the BRCA1 gene in 1994 and the BRCA2 gene in 1995. The Company developed a highly sophisticated laboratory process to analyze the genes for ...
https://myriad.com/patients-families/disease-info/breast-cancer/
Up to ten percent of breast cancer cases are caused by mutations in the BRCA1 or BRCA2 genes 3 , which can be inherited through generations of family members.
https://myriad.com/mychoicecdx-astrazeneca/
Retest your patients with advanced ovarian cancer who were negative for BRCA1/2 mutations at no added cost* · Knowing HRD status is important to determine ...
https://investor.myriad.com/news-releases/news-release-detail/11351/
... BRCA1/2 mutation. When a family history of breast and/or ovarian cancer are also present, testing women with early-onset CIS may increase the likelihood of ...
https://myriad.com/oncology/bracanalysiscdx-patient-guide/
What is BRCA1/2 and how does BRCA status influence my cancer treatment? Everyone is born with BRCA genes, and the proteins produced by the BRCA1 and BRCA2 ...
https://investor.myriad.com/news-releases/news-release-detail/10771/
... BRCA1 and/or BRCA2 genes as a standalone test or in conjunction with gene panels, but Gene by Gene will continue to offer such tests outside of North America .